These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16493449)

  • 41. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
    Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
    Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population.
    Ernst A; Jacobsen B; Østergaard M; Okkels H; Andersen V; Dagiliene E; Pedersen IS; Thorsgaard N; Drewes AM; Krarup HB
    Scand J Gastroenterol; 2007 Dec; 42(12):1445-51. PubMed ID: 17852840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians.
    Juyal G; Amre D; Midha V; Sood A; Seidman E; Thelma BK
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1325-32. PubMed ID: 17892524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences in genetic background between active smokers, passive smokers, and non-smokers with Crohn's disease.
    van der Heide F; Nolte IM; Kleibeuker JH; Wijmenga C; Dijkstra G; Weersma RK
    Am J Gastroenterol; 2010 May; 105(5):1165-72. PubMed ID: 19953089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study.
    Ferraris A; Torres B; Knafelz D; Barabino A; Lionetti P; de Angelis GL; Iacono G; Papadatou B; D'Amato G; Di Ciommo V; Dallapiccola B; Castro M
    Inflamm Bowel Dis; 2006 May; 12(5):355-61. PubMed ID: 16670523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.
    Rigoli L; Romano C; Caruso RA; Lo Presti MA; Di Bella C; Procopio V; Lo Giudice G; Amorini M; Costantino G; Sergi MD; Cuppari C; Calabro GE; Gallizzi R; Salpietro CD; Fries W
    World J Gastroenterol; 2008 Jul; 14(28):4454-61. PubMed ID: 18680223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of CARD15 polymorphisms in Korean patients with ankylosing spondylitis reveals absence of common variants seen in western populations.
    Kim TH; Rahman P; Jun JB; Lee HS; Park YW; Im HJ; Snelgrove T; Peddle L; Hallett D; Inman RD
    J Rheumatol; 2004 Oct; 31(10):1959-61. PubMed ID: 15468360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus.
    De Jager PL; Graham R; Farwell L; Sawcer S; Richardson A; Behrens TW; Compston A; Hafler DA; Kere J; Vyse TJ; Rioux JD
    Genes Immun; 2006 Jun; 7(4):327-34. PubMed ID: 16642031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CARD15/NOD2 single nucleotide polymorphisms do not confer susceptibility to type I psoriasis.
    Plant D; Lear J; Marsland A; Worthington J; Griffiths CE
    Br J Dermatol; 2004 Sep; 151(3):675-8. PubMed ID: 15377357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CARD15 variants in patients with sporadic Parkinson's disease.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Juzwiak S; Kurzawski G; Tan EK; Drozdzik M
    Neurosci Res; 2007 Mar; 57(3):473-6. PubMed ID: 17174426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of DLG5 and SLC22A5 gene polymorphisms in Malaysian patients with Crohn's disease.
    Chua KH; Lian LH; Kee BP; Thum CM; Lee WS; Hilmi I; Goh KL
    J Dig Dis; 2011 Dec; 12(6):459-66. PubMed ID: 22118696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic variants in TNF-alpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort.
    Tremelling M; Waller S; Bredin F; Greenfield S; Parkes M
    Inflamm Bowel Dis; 2006 Mar; 12(3):178-84. PubMed ID: 16534418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CARD15 gene variants and risk of reoperation in Crohn's disease patients.
    Maconi G; Colombo E; Sampietro GM; Lamboglia F; D'Incà R; Daperno M; Cassinotti A; Sturniolo GC; Ardizzone S; Duca P; Porro GB; Annese V
    Am J Gastroenterol; 2009 Oct; 104(10):2483-91. PubMed ID: 19638967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease.
    de Ridder L; Weersma RK; Dijkstra G; van der Steege G; Benninga MA; Nolte IM; Taminiau JA; Hommes DW; Stokkers PC
    Inflamm Bowel Dis; 2007 Sep; 13(9):1083-92. PubMed ID: 17476680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease.
    Lakatos PL; Fischer S; Claes K; Kovacs A; Molnar T; Altorjay I; Demeter P; Tulassay Z; Palatka K; Papp M; Rutgeerts P; Szalay F; Papp J; Vermeire S; Lakatos L;
    Inflamm Bowel Dis; 2006 May; 12(5):362-8. PubMed ID: 16670524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of association.
    Jenisch S; Hampe J; Elder JT; Nair R; Stuart P; Voorhees JJ; Schreiber S; Kabelitz D; Christophers E; Weichenthal M
    Arch Dermatol Res; 2006 Mar; 297(9):409-11. PubMed ID: 16402184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
    Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.